Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Vidhyalakshmi Ramesh"'
Publikováno v:
International Journal of Women's Dermatology, Vol 10, Iss 3, p e180 (2024)
Externí odkaz:
https://doaj.org/article/2d108d6299874859bb67ac8db22ecc69
Autor:
Divya Bhargava, Cathleen Drilling, Todd E. DeFor, Claudio G. Brunstein, Bharat Thyagarajan, Najla El Jurdi, Shernan G. Holtan, Armin Rashidi, Erica Warlick, Vidhyalakshmi Ramesh, John Rogosheske, Mukta Arora, Smita Bhatia, Daniel J. Weisdorf
Publikováno v:
Bone Marrow Transplantation. 57:1079-1085
The use of opioids and/or benzodiazepines in older adults (65 y+) who received an allogeneic hematopoietic cell transplant (HCT) is not known. In March 2016, the CDC released its strongest guidelines against prescription of opioids and co-prescriptio
Autor:
Niassan Beyzaie, Peter Parham, Stephen R. Spellman, Steven G.E. Marsh, Vidhyalakshmi Ramesh, Neda Nemat-Gorgani, Jill A. Hollenbach, Wesley M. Marin, Lisbeth A. Guethlein, Daniel J. Weisdorf, Paul Norman, Tao Wang, Johannes Schetelig, Jeffrey S. Miller, Sarah Cooley
Publikováno v:
The Journal of Immunology. 206:3064-3072
In the treatment of acute myelogenous leukemia with allogeneic hematopoietic cell transplantation, we previously demonstrated that there is a greater protection from relapse of leukemia when the hematopoietic cell transplantation donor has either the
Publikováno v:
The British journal of dermatologyReferences. 187(6)
Autor:
Marie Hu, Vidhyalakshmi Ramesh, Nuttavut Sumransub, Alma Habib, Joseph E. Maakaron, Veronika Bachanova
Publikováno v:
Transplantation and Cellular Therapy. 29:S54
Autor:
Shivjot Singh, Todd E DeFor, Daniel Weisdorf, Claire Carrier, Mary Lee Nick, Elizabeth Schafer, Claudio G. Brunstein, Najla El Jurdi, Shernan Holtan, Joseph E. Maakaron, Armin Rashidi, Vidhyalakshmi Ramesh, Hok Sreng Te, Mukta Arora, Fiona He
Publikováno v:
Transplantation and Cellular Therapy. 28:S153
Publikováno v:
Journal of Clinical Oncology. 40:658-658
658 Background: Patients with advanced GI cancer have a high prevalence of CACS. Medications used for CACS have limited efficacy, unwanted side effects, and high costs. We sought to describe the prescribing patterns of medications for CACS in patient
Autor:
Divya Bhargava, Armin Rashidi, Bharat Thyagarajan, Vidhyalakshmi Ramesh, Erica D. Warlick, Claudio G. Brunstein, Shernan G. Holtan, John Rogosheske, Daniel J. Weisdorf, Todd E. DeFor, Smita Bhatia, Mukta Arora, Najla El Jurdi
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S133-S134
Background The American Geriatric Society has established criteria (Beers criteria) for Potentially Inappropriate Medications (PIMs) in older (65+y) adults (J Am Geriatr Soc. 2019 Apr;67(4):674-694). The use of PIMs in allogeneic hematopoietic cell t
Publikováno v:
SSRN Electronic Journal.
The obstacles that lead to the under-representation of women in leadership and upper level management positions are commonly described in scholarly works and the media as glass ceilings (Barreto et al., 2009; McLeod, 2008; Weyer, 2007). The term glas